BioSig Technologies (NASDAQ: BSGM) has signed a definitive share exchange agreement with Streamex Exchange Corporation, marking a significant pivot from medical technology to real-world asset tokenization. Under the agreement, Streamex will become a wholly-owned subsidiary of BioSig, with Streamex shareholders receiving 75% of BioSig's fully diluted common stock. The combined company will be led by Streamex's Co-Founder Henry McPhie as CEO, while Morgan Lekstrom will serve as Chairman.
The transaction brings notable strategic advisors, including Frank Giustra, founder of Wheaton Precious Metals and GoldCorp, positioning the company to tap into the $142.85 trillion global commodity market through blockchain technology. Initially, Streamex shareholders will receive 19.9% of BioSig's outstanding common stock, with the full 75% stake subject to shareholder approval.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.